Загрузка...
Development and Optimization of a GMP-Compliant Manufacturing Process for a Personalized Tumor Lysate Dendritic Cell Vaccine
With the emergence of immune checkpoint inhibitors and adoptive T-cell therapies, there is a considerable interest in using personalized autologous dendritic cell (DC) vaccines in combination with T cell-targeting immunotherapies to potentially maximize the therapeutic impact of DC vaccines. Here, w...
Сохранить в:
| Опубликовано в: : | Vaccines (Basel) |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7157441/ https://ncbi.nlm.nih.gov/pubmed/31947581 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines8010025 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|